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Abstract
The new potential tracer of bone imaging, AHBDP-Sn(II)-TcO.3H20 was synthesized by
reducing the TcO4" to TcO2+ in the presence of AHBDP and Sn(ll)’s reducing agent. We found that
tin rapidly forms a stable complex with AHBDP, giving AHBDP-Sn(II).3H20. In the excess of AHBDP-
Sn(ll).3H20, the AHBDP-Sn(II).3H20 coordinates with TcO2+ to give AHBDP-Sn(II)-TcO.3H20
which could polymerise or oligomerise to give hydrophobic species. The overall process appears as
a first-order reaction (k= 0.67 +_. 0.005 s’l). In rats, the fixation of AHBDP-Sn(II)-99mTcO. 3H20 on
bone is homogeneous and the scintigraphic images have the same quality as those of
1-hydroxymethane-l,l-diphosphonate-Technetium (HMDp-99mTc). The activity in non-target
organs was neglible.
INTRODUCTION
4-amino-l-hydroxybutane-l,l-diphosphonate (AHBDP) is a diphosphonate derivative.
Diphosphonate-technetium complexes such as 1-hydroxymethane-l,l-diphosphonate-
technetium (HMDP-Tc), 1-hydroxyethane-l,l-diphosphonate (HEDP-Tc) (Chart 1), etc. are widely
used in bone scintigraphy. It is well-known that these complexes can exist as monomers, polymers
or oligomers, and also that in technetium, in different oxidation states, frequently as +4 and +5 as
well as +3 and +6, different valence states may exist together, depending on the experimental
conditions 1-4.
The subsequent reduction of TcO4(’) from +7 to a lower level of oxidation in the presence of
various ligands is essential for radiopharmaceuticals. Stannous chloride (SnCI2) is frequently used
as a reducing agent for TcO4(’). Unfortunately, in aqueous solution, Sn(ll) is easily hydrolyzed and.
oxidized. Its solution is stable only in the presence of hydrochloric acid 5-9. However, it has been
reported that a large excess of SnCI2 in labelling systems affects not only the quality, purity and
stability of the radiopharmaceuticals, but also the biological behaviour of 99mTc-complexes.
Sn(ll) forms chelates with many substrates so that the labelling procedures generally yield a mixture
of tin and technetium chelates 10-12 Deutsch proposed that tin can and does bind to T
complexes 1.
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Huigen et al. showed that the HEDP-Sn(II)-Tc has a molecular charge between -4 and -9 at
pH 7 and that in an acidic pH, the charge increases 13 .Tji et al showed that the diphosphonate-
technetium complexes adsorb on calcium phosphate, as a model of bone adsorption. For the
-Tc(lll), -Tc(IV), and HEDP-Tc(V) complexes, the adsorption on calcium phosphate increases in the
following order Tc(V) < Tc(IV) < Tc(lll) 3.
It was observed that the chemical structure of complexes affects the biological behavior.
According to its chemical structure, we can predict its biological function. However, the chemical
structure of the technetium-complexes was not clearly shown. In this study, we want to report the
synthesis and physico-chemical characterisation of the AHBDP-Sn(II)-Tc by using AHBDP-
Sn(II).3H20 as a chelating and reducing agent for the technetium. We have also investigated its
biodistribution in rats.
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MATERIALS AND METHODS
AHBDP was synthesized following the published procedure14"15 and its purity was controlled
by NMR spectroscopy. Stannous chloride (SNCI2.2 H20 was obtained from Sigma. Ammonium
pertechnetate (99TcO4.NH3) was obtained from Dupont and sodium pertechnetate (99mTcO4.Na)
eluted from the Mo-99mTc generator, was obtained from Cis-Bio Int. HCL normapur grade was
obtained from Prolabo. Cocathiline was obtained from Chimika-Biochemika. Whatman paper no. 3
MM was obtained from Bioblock (France). All solutions were prepared with bi-distilled water
saturated with nitrogen.
Spectrophotometric measurements were done with a HEWLETT PACKARD 8452 A
spectrophotometer and the optical path was cm (URA. CNRS 2056). NMR spectra were recorded,
using a NMR JEOL model Fx 100.
Paper chromatograms (methanol:water 80:20) was interpreted with a Chromelec Nu-102
radiochromatogram.
The AHBDP is dissolved in water and its solution is stable for many hours.
SnCI2 was dissolved in a 0,1 N HCI solution. The dissociated constant, ka, is equal to
5.7 10-3 M’l.s"1 6.The Sn(ll) concentration is measured spectrophotometrically by complexation
with cocathiline, using 523 2773 M’l.cm"1.
The 99TCO4 (’) concentration is determined spectrophotometrically, using
E248 6220 M"1 .cm"1.
Potentiometric titrations were done with a CG-837 pH meter at 22C, using the Gerat( Schott
glass electrode, model N 52A. A solution (25 ml) containing 0:1, 1:1 and 1:3 metal to ligand molar
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ratios was introduced into the titration cell, and the proton ion concentration was determined by a
number of successive readings after addition of small quantity of standard 0.01 N NaOH.
The tissue distribution was performed at 30 minutes, 1, 2 and 3 hours post injection of
74 MBq per rat. After dissection of rat, organs sample activities were counted by NaI(TI) scintillator
(Packard COBRA 5010).
RESULTS
I. Complexation of AHBDP-Sn(II)
The kinetic studies and final product analysis were performed for several concentration ratios
of AHBDP and Sn(ll). The pH value of the solutions varied between to 11.
1.1. Spectrophotometric studies:
The initial AHBDP and Sn(ll) concentrations varied from 10-4 to 10-2 M. The solution of
AHBDP did not absorb UV-Vis light. At pH 3, the mixture solution of AHBDP and Sn(ll) gave an
absorption band at 224 nm. In alkaline solution, the absorbance at this wavelength decreased while
a new band appeared at 276 nm. The solutions were stable for less than 5 hours.The reaction was
done in less than 1 minute.
For the study of the complexes, two series of experiments were performed. In one series, the
concentration of AHBDP was varied in the presence of a constant excess of Sn(ll) ([Sn(ll)] =10-2 M).
However, in the other, the Sn(ll) concentration was variable and the AHBDP constant; [AHBDP]
10-2 and 5 x 10-2 M. The pH of the solutions was adjusted to 3, using 1.0 N HCI. The formula of the
complexes was further investigated by spectrophotometrical measurements16. The absorption
band at 224 nm increased as the molar ratios of Sn(II):AHBDP increased. This absorbance was
stable when the molar ratio was equal to 1. In these conditions, the reaction was done with
stoichiometry 1:1.
!.2. Potentiometric titrations of AHBDP-Sn(II)
The titration curves are illustrated in Figure for AHBDP chelate of Sn(ll) at 1:0, 1:1 and 1:3
ratios of metal to ligand. There is evidence of complex formation between AHBDP and Sn(ll).
Titrations of equimolar amounts of AHBDP and Sn(ll) resulted in a steep rise at [NaOH] 0.002 M,
corresponding to the formation of a 1:1 complex. A 1:3 molar ratio resulted in steep rise at
[NaOH] 0.0014 M. This indicates that AHBDP-Sn(II) exists as 1:1 complex.
In purified water, AHBDP is present in the zwitterionic form. The PKa of AHBDP were
determined, pkal, Pka2 and Pka3 are equal to 3, 6.8 and 10.
In order to identify the products of the reaction, two series of experiments were carried out in
the following conditions" [AHBDP] [Sn(ll)] =10-2 M. In the first series the pH was equal to 2, while
in the second, it was adjusted to 11 with NaOH. After the completion of the reaction, the solutions
were lyophilized and the products were analyzed by 31p.NMR. It should be noted that the
lyophilized powder at pH 11 was instable in the ambient conditions; its color changed from white to
black and became insoluble in water. On the other hand, the lyophilized powder at pH 2 was stable
and soluble in water. The 31 p. NMR spectrum was very different from the one that obtained from
the pure AHBDP (The pure AHBDP 5 19.5 ppm; In complex solutions this peak has disappeared).
This indicated that there is a modified electronic environment of phosphorus and all of AHBDP is
complexed.
2. Complexation of AHBDP-Sn(II)-Tc
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Figure 1" Potentiometrie titrations of AHBDP-Sn(II) for (0) 1:0, () 1:1 (+) 1:3 molar ratios of metal ligand,
[AHBDP] 10-3 M, [NaOH] 0.1 N.
Temps (mn)
Fig. 2: Complexation of AHBDP-Sn(II) by Tc in the excess solution of AHBDP-Sn(II), [AHBDP-Sn(II)] 10-3 M,
pH 3; (o) [TcO4" 7.9 x 10.5 M and (#) [TcO4" 1.6 x 10-4 M. Computed monoexponential
Inset" Variation of absorbance at 400 nm, at plateau level, of AHBDP-Sn(II) chelates Tc, in function of
[TcO4"]. Line is "linear least-squares fit" of data.curves (points are experimental).
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We have verified that AHBDP-Sn(II) solutions were stable for several hours and we always
used fresh solutions in our experiments.
2.1. Spectmphotometric studies
In this series of experiments, the concentration of AHBDP-Sn(II) varie from 10"6 to 2 x 10-3 M
and the concentration of TcO4(’) varied from 10-6 to 10"2 M. The pH varied from 1.5 to 11.
Immediately after the mixture of AHBDP-Sn(II) and TcO4(’) the solution became yellow. For
the following series of solutions with equimolar amounts of AHBDP-Sn(II) and TcO4(’) and the
excess of the TcO4(’), the solutions became opaque and were composed of a brown precipitate.
For the excess solutions of AHBDP-Sn(II), [AHBDP-Sn(II)] 10[TCO4(’)], the evolution of the
absorption spectra was investigated. The absorbance at 224 nm immediately increased after the
addition of TcO4(’) and then decreased before stabilising. There was a new absorption band
at 400 nm. The evolutions of the absorbance at 400 nm are reported in figure 2. A pseudo plateau
was reached by absorbance, within 25 minutes; however, the absorption spectra changed slowly
and a yellow precipitate appeared over 72 hours. It should be noted that the pseudo plateau was
attained independently of the initial concentrations of the reagent, as it can be seen in the inset of
Figure 2. In these conditions of stoichiometry 1:1 the composition of the solution at the pseudo
plateau was thus independent of the reagent concentrations and the average extinction for the
complexes could be calculated using the slope of the straight line of inset of Figure 2
2190 M"l.cm"1 All curves, such as the one in figure 2, could be analysed according to a first-
order kinetic law, with a rate constant of 0.67 + 0.005 s"1
We have verified that the formation of the complex was independent of pH and that complex
was stable as a function of dilution.
2.2 Potentiometric titrations of AHBDP-Sn(II)-Tc
The titration curves are illustrated in figure 3 for AHBDP-Sn(II) chelates Tc for 1:0, 1:10 and
1:25 ratios of metal to ligand. In steep inflection, the three curves were identical, there were no
protons released from the complex for pH < 6. It is possible that after the reduction of the TcO4(’) to
TcO(2+), the AHBDP-Sn(II) chelates TcO(2+) forming a complex as shown in scheme 2. The .. could
either polymerise or oligomerise to give the formation of the hydrophobic species, indicated by the
yellow precipitate in the solution after 72 hours.
3. Biodistribution of AHBDP-Sn(II)-99mTc in rat
3.1 Preparation of the AHBDP-Sn(II)-99mTc
Paper chromatography of AHBDP-Sn(II)-99mTc (prepared under the conditions described
above) showed that all the activity was Iocalised at the origin. These results showed that the
AHBDP-Sn(II)-99mTc was almost free from Na99mTco4 The yield of labelling was about 96 % and
the complexes was stable for at least two hours.
3.2. Tissue distribution
Uptake of the AHBDP in various organs of rats at 0.5,1, 2 and 3 hours post injection, indicated
that the greater part of the complex was distributed in the rats’ bones, kidneys and urinary bladders.
Lungs, spleen, liver, heart and muscle showed negligible activity. Per gram organ uptake, as
shown in table 1, was found to be highest in bone as compared to the other organs.
Studies on blood clearance of the AHBDP showed that during the initial post injection period,
there was a rapid loss of activity in the blood and it was reduced to only 6% of the injection dose
205Vol. 2, No. 4, 1995 Synthesis of4-Amino-l-Hydroxy-Butane-l,l-Diphosphonate
within 30 minutes. Thereafter, further clearance was lower at hour post injection, the blood still
showed 2% of the injected activity.
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Fig. 3" Potentiometric titrations of AHBDP-Sn(II)-Tc for (o) 1:0, (/) 1:10 and (A) 1:25 molar ratios of metal
ligand, [AHBDP-Sn(II)] 10"3 M, [NaOH] 0.1 N.
Organs
tibia
vertebra
It. kidney
rt. kidne),
liver
spleen
lungs
heart
muscle
blood
30 min
HMDP
39
0.9
0.5
0.04
0.12
0.05
3
AHBDP
29
33
3.1
1.6
0.3
1.4
0.13
13
6.5
hour
HMDP
41
17
0.22
0.33
0.06
0.04
0.01
1.05
0.5
AHBDP
29.7
11.9
1.43
0.5
0.2
0.38
0.04
2.1
2 hours
HMDP
41.5
20
0.23
0.22
0.4
0.04
0.04
0.01
5
0.3
AHBDP
46
21
0.5
0.4
0.1
0.03
3.96
2.8
3 hours
HMDP
49
22
0.3
0.5
0.04
0.01
1.6
0.3
AHBDP
2O.8
0.64
0.6
0.4
0.25
0.15
O.O3
2.1
2.14
Table 1; Accumulated activities in different organs of rats of the AHBDP and the HMDP at various time
post injection of 74 MBq per rat. The rats were dissected and organ sample activities were counted by gamma
countor. The activities were calculated according to the following equation, (Act./Org.) x (rat wt./DI).
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DISCUSSION
1. Complexation ol AHBDP-Sn(II)
The experimental data indicated that Sn(ll) has formed a stable 1:1 complex with AHBDP. Its
oxidation state is +2. This is in agreement with the previous work performed by Nakayama et al11-12.
We propose, for the overall reaction, the mechanism shown in scheme 1, at pH 3, where the
AHBDP is in the predominating species 2= and the Sn(ll) is solvated. The first step could be the
exchanging of H20 by oxygen anions leading to the hydrated complexes. Next, the coordination of
Sn(ll) is stabilized by the atom donor, nitrogen atom of the amine group, with the elimination of one
molecule of water, corresponding to 4.
2. Complexation of AHBDP-Sn(II)-99Tc
The study of spectrophometric and potentiometric titrations shows that the technetium has
formed a complex, chelated by AHBDP-Sn(II).3H20 with hydroxyl groups, giving AHBDP-Sn(II)-
TcO.3H2Oo This is in agreement with the previous works reported by Tji et al. and Deutsch et al.o It
was observed that for equimolar amounts of AHBDP-Sn(II) and TcO4(’) and the excess of the
TcO4(’), the solutions are almost formed with the brown precipitated (as mentioned above) and we
propose that the technetium remains at the degree of oxidation +4. The Tc(IV) formed the complex
with AHBDP-Sn(II).2H20 and/or hydrolyzed to give TcO2.2H20 that precipitated. For the excess of
ligand, the reaction was done in several steps. The first step was the reduction of TcO4(’)to TcO(2+)
by AHBDP-Sn(II).2H20. The second step was the chelation of TcO(2+) by BHADP-Sn(II).2H20 that
we propose the mechanism in scheme 2. The first step o the reaction was the exchange of two
molecules of water by the hydroxyl function of the phosphonic groups, including the addition of the
atom donor, Sn(ll) to Tc, giving the hydrated complexes. The product had intramolecular
rearrangement, with the elimination of one molecule of water to give The second step was the
polymerization or oligomerization of the 5 to give the hydrophobic species. Either the first or the
second step of the mechanism could have given the constant rate of 0.67 +_ 0.005 s"1
3. Biodistribution
It is clear that AHBDP-Sn(II)-99mTcO.3H20 and HMDp-99mTc has a high affinity to bone. The
kinetics and saturation time of the uptake to bone was not significantly different in either complex.
AHBDpoSn(II)-99mTcO.3H2O is eliminated more rapidly than HMDp-99mTc. The signal/background
ratio of AHBDP-Sn(II)-99mTcO.3H20 was lower than that of HMDp-99mTc, assessed by tibia and
vertibra versus blood (figure 4) and muscle (Figure 5). Accumulated activities in non-target organs
was negligible. The biological behavior of AHBDpoSn(II)-99mTcO.3H2O was closed to other
diphosphonate compounds; HMDP,HEDP, etc. We found that the AHBDP-Sn(II)-TcO. 3H20
complex was stable, with the variation of pH and dilution. In rats, it fixed homogeneously on bone
and the scintigraphic images had the same quality as that of HMDp-99mTc image. We propose to
consider the AHBDP-Sn(II)-99mTcO.3H20 as a good tracer for bone imaging.
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Fig.4: Variation of the ratio of the activities of bone related to the activities in blood, data form table 1.
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